Company Analysis

Rezolute, Inc. (RZLT)

Nasdaq: RZLT · Pharmaceutical Preparations · Redwood City, CA · filing with the SEC since 2011
Grade4.6
◀ Past 3.9● Present 5.6▶ Future 4.2
6 est.

Who runs Rezolute, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Elam Nevan C
CEO. First filing Feb 2013, latest Jul 7, 2026, 4 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
20 people on the record since 2013
Officerssales are open-market, Oct 23, 2025 to Oct 23, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Evans DaronCFOJan 2024Oct 23, 2026none
Karnawat Sunil RatilalChief Commercial OfficerAug 2025Sep 3, 2026none
Elam Nevan CCEOFeb 2013Jul 7, 2026none
Roberts Brian KennethChief Medical OfficerOct 2020Jul 7, 2026none
Directorssales are open-market, Oct 23, 2025 to Oct 23, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hogenhuis WladimirdirectorMar 2021Dec 17, 2025none
Fauchet PhilippedirectorSep 2020Nov 21, 2025none
Harris ErikdirectorMar 2025Nov 21, 2025none
Kim Young-JindirectorMar 2019Nov 21, 2025none
Kreher NerissadirectorMar 2021Nov 21, 2025none
Labrucherie Gil MdirectorNov 2019Nov 21, 2025none
Earlier names on the record12, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton RZLT · research, not advice